NUVB (Nuvation Bio) Short Interest


NUVB Nuvation Bio Inc NUVB
33 GF Score
Price $5.65
! 3 Warning Signs
View Full Analysis

What is Nuvation Bio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NUVB vs GLUE, ATAI, BHVN: Short Interest Comparison

For the Biotechnology subindustry, Nuvation Bio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Short Interest distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Short Interest falls into.


NUVB
33GF Score
Nuvation Bio Inc NUVB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvation Bio Business Description

Address 1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score

Get the complete analysis for NUVB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.65
Price